|
⚲
|
| Keyboard |
| Cahill Thomas
✚
|
|
|---|---|
| CIK # | 0001922939 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001922939] | |
| 4 | [0001922939] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Prime Medicine Inc | |
| Cahill Thomas |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
|
2025-08-01 | Grant | 45,000 | ||
|
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
|
2025-08-01 | Disposed to issuer | 45,000 | ||
|
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
|
2025-08-01 | Disposed to issuer | 39,062 | ||
|
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
|
2025-08-01 | Grant | 39,062 | ||
|
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
|
2025-06-04 | Grant | 55,000 | $0.00 | |
|
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
|
2024-06-12 | Grant | 45,000 | $0.00 | |
|
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
|
2023-06-14 | Grant | 39,062 | $0.00 | |
|
Prime Medicine Inc PRME
Common Stock
|
2022-10-24 | Conversion | 4,905,679 | ||
|
Prime Medicine Inc PRME
Series A Convertible Preferred Stock · derivative
|
2022-10-24 | Conversion | 9,999,999 | $0.00 | |
|
Prime Medicine Inc PRME
Series B Convertible Preferred Stock · derivative
|
2022-10-24 | Conversion | 5,250,781 | $0.00 | |
|
Prime Medicine Inc PRME
Common Stock
|
2022-10-24 | Buy | 400,000 | $17.00 | 6,800,000 |